Polymorphisms of CXCR3-binding chemokines in type 1 diabetes

Human Immunology

Volumn 70, Issue 7, 2009, Pages 552-555

  Brück, Patrick ^a   Bartsch, Wiebke ^b   Penna Martinez, Marissa ^b   Kahles, Heinrich ^b   Seidl, Christian ^c   Böhme, Angelika ^a   Badenhoop, Klaus ^b   Ramos Lopez, Elizabeth ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Institute of Transfusion Medicine and Immunohematology   (Germany)

Author keywords

CXCL10; CXCL9; HLA; Type 1 diabetes

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE; HLA ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; MESSENGER RNA; THREONINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GENETIC POLYMORPHISM; GERMANY; HAPLOTYPE; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CHEMOKINE CXCL9; DIABETES MELLITUS, TYPE 1; FAMILY HEALTH; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; GERMANY; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 67449141651     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.031     Document Type: Article

References (26)

1. Roep B.O. The role of T-cells in the pathogenesis of type 1 diabetes: From cause to cure. Diabetologia 46 (2003) 305-321
2. Frigerio S., Junt T., Lu B., Gerard C., Zumsteg U., Hollander G.A., and Piali L. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8 (2002) 1414-1420
3. Christen U., McGavern D.B., Luster A.D., von Herrath M.G., and Oldstone M.B. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171 (2003) 6838-6845
4. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187 (1998) 129-134
5. Siveke J.T., and Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 160 (1998) 550-554
6. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., et al. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 184 (1996) 963-969
7. Sallusto F., Lenig D., Mackay C.R., and Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187 (1998) 875-883
8. Rotondi M., Romagnani P., Brozzetti A., Santeusanio F., Serio M., Falorni A., et al. Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45 (2002) 1107-1110
9. Rotondi M., Lazzeri E., Romagnani P., and Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: An expanding field. J Endocrinol Invest 26 (2003) 177-180
10. Rotondi M., Falorni A., De Bellis B.A., Laureti S., Ferruzzi P., Romagnani P., et al. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J Clin Endocrinol Metab 90 (2005) 2357-2363
11. Buttmann M., Merzyn C., Hofstetter H.H., and Rieckmann P. TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response. J Neuroimmunol 190 (2007) 170-176
12. Antonelli A., Fallahi P., Rotondi M., Ferrari S.M., Serio M., and Miccoli P. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg 93 (2006) 1226-1231
13. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Barani L., et al. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin Endocrinol (Oxf) 64 (2006) 189-195
14. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Paolicchi A., et al. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152 (2005) 171-177
15. Garcia-Lopez M.A., Sancho D., Sanchez-Madrid F., and Marazuela M. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86 (2001) 5008-5016
16. Donner H., Seidl C., Van der Auwera A.B., Braun J., Siegmund T., Herwig J., et al. HLA-DRB1*04 and susceptibility to type 1 diabetes mellitus in a German/Belgian family and German case-control study. The Belgian Diabetes Registry. Tissue Antigens 55 (2000) 271-274
17. Spielman R.S., McGinnis R.E., and Ewens W.J. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52 (1993) 506-516
18. Bergholdt R., Nerup J., and Pociot F. Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes. J Med Genet 42 (2005) 17-25
19. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., et al. Type 1 diabetes: Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 54 (2005) 2995-3001
20. Cox N.J., Wapelhorst B., Morrison V.A., Johnson L., Pinchuk L., Spielman R.S., et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 69 (2001) 820-830
21. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39 (2007) 857-864
22. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu Rev Immunol 22 (2004) 891-928
23. Lazzeri E., and Romagnani P. CXCR3-binding chemokines: Novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 109-118
24. Galimberti D., Scalabrini D., Fenoglio C., Comi C., De Riz R.M., Venturelli E., et al. CXCL10 haplotypes and multiple sclerosis: Association and correlation with clinical course. Eur J Neurol 14 (2007) 162-167
25. Venturelli E., Galimberti D., Fenoglio C., Lovati C., Finazzi D., Guidi I., et al. Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease. Neurosci Lett 404 (2006) 217-221
26. Zhang J., Noguchi E., Migita O., Yokouchi Y., Nakayama J., Shibasaki M., and Arinami T. Association of a haplotype block spanning SDAD1 gene and CXC chemokine genes with allergic rhinitis. J Allergy Clin Immunol 115 (2005) 548-554